| Year |
Citation |
Score |
| 2018 |
Sampson C, James M, Whynes D, Eleuteri A, Harding S. OP60 Optimising Risk-Based Screening: The Case Of Diabetic Eye Disease International Journal of Technology Assessment in Health Care. 34: 21-21. DOI: 10.1017/S0266462318001046 |
0.534 |
|
| 2016 |
Whynes D, Duffy SW, Baldwin DR, Devaraj A, Field JK. Abstract 3458: UK lung cancer screening trial (UKLS) cost effectiveness: similarities with the NLST high-risk quintiles Cancer Research. 76: 3458-3458. DOI: 10.1158/1538-7445.Am2016-3458 |
0.432 |
|
| 2016 |
Whynes D, Sach T. Sex, benevolence and willingness to pay for screening International Journal of Social Economics. 43: 982-997. DOI: 10.1108/Ijse-09-2014-0192 |
0.327 |
|
| 2015 |
Sharp L, Cotton S, Cruickshank M, Gray N, Smart L, Whynes D, Little J. Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial. The Journal of Family Planning and Reproductive Health Care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. PMID 26376822 DOI: 10.1136/Jfprhc-2015-101170 |
0.338 |
|
| 2013 |
Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, ... ... Whynes D, et al. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technology Assessment (Winchester, England). 17: vii-xiv, 1-95. PMID 23489892 DOI: 10.3310/Hta17110 |
0.308 |
|
| 2013 |
Field JK, Baldwin D, Devaraj A, Brain K, Eisen T, Holemans J, Ledson M, Screaton N, Rintoul RC, Yadegarfar G, Hands C, McRonald FE, Lifford K, Whynes D, Kerr K, et al. Abstract 3631: United Kingdom lung cancer screening trial (UKLS): First 88897 approaches. Cancer Research. 73: 3631-3631. DOI: 10.1158/1538-7445.Am2013-3631 |
0.381 |
|
| 2012 |
Sharp L, Cotton S, Thornton A, Gray N, Cruickshank M, Whynes D, Duncan I, Hammond R, Smart L, Little J. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 165: 318-25. PMID 22921577 DOI: 10.1016/J.Ejogrb.2012.08.001 |
0.309 |
|
| 2011 |
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Williamson P, Whynes D. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax. 66: 736-7. PMID 21724746 DOI: 10.1136/Thoraxjnl-2011-200351 |
0.381 |
|
| 2011 |
Field JK, Duffy S, Baldwin D, Brain KE, Eisen T, Hands CJD, Kerr KM, Page R, Parmar M, Wald N, Weller D, Whynes D, Williamson P, Hansell D. United Kingom lung cancer screening (UKLS) trial [Conference abstract] Journal of Thoracic Oncology. DOI: 10.1097/01.Jto.0000399290.73317.Eb |
0.329 |
|
| 2005 |
Frew EJ, Wolstenholme JL, Whynes DK. Eliciting relative preferences for two methods of colorectal cancer screening. European Journal of Cancer Care. 14: 124-31. PMID 15842459 DOI: 10.1111/J.1365-2354.2005.00515.X |
0.347 |
|
| 2003 |
Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. International Journal of Technology Assessment in Health Care. 19: 384-95. PMID 12862195 DOI: 10.1017/S0266462303000345 |
0.301 |
|
| 2001 |
Philips Z, Whynes D, Parnham S, Slack R, Earwicker S. The role of community pharmacists in prescribing medication for the treatment of head lice. Journal of Public Health Medicine. 23: 114-20. PMID 11450927 DOI: 10.1093/Pubmed/23.2.114 |
0.327 |
|
| 2001 |
Frew E, Wolstenholme J, Whynes D. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. Journal of Health Services Research & Policy. 6: 85-91. PMID 11357249 DOI: 10.1258/1355819011927279 |
0.371 |
|
| 2000 |
Avery AJ, Rodgers S, Heron T, Crombie R, Whynes D, Pringle M, Baines D, Petchey R. A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs. Bmj. 321: 276-281. PMID 10915132 DOI: 10.1136/Bmj.321.7256.276 |
0.317 |
|
| 2000 |
Miller P, Whynes D, Reid A. An economic evaluation of occupational health. Occupational Medicine (Oxford, England). 50: 159-63. PMID 10912357 DOI: 10.1093/Occmed/50.3.159 |
0.31 |
|
| 1998 |
Baines D, Whynes D. The use of the ASTRO-PU and the ASTRO(97)-PU in the setting of prescribing budgets in English general practice. Journal of Clinical Pharmacy and Therapeutics. 23: 229-234. PMID 9831975 DOI: 10.1046/J.1365-2710.1998.00157.X |
0.301 |
|
| 1997 |
Wolstenholme J, Whynes D. OP32. The cost of cervical cancer: Implications for screening European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85912-6 |
0.382 |
|
| 1997 |
Wolstenholme J, Whynes D. OP31. The cost of breast cancer: Implications for screening European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85911-4 |
0.349 |
|
| 1997 |
Whynes D, Walker A, Neilson A. OP30. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85910-2 |
0.381 |
|
| 1993 |
Whynes D, Walker A, Chamberlain J, Hardcastle J. Screening and the costs of treating colorectal cancer. British Journal of Cancer. 68: 965-968. PMID 8217610 DOI: 10.1038/Bjc.1993.462 |
0.393 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1994 |
Gladman J, Whynes D, Lincoln N. Cost Comparison of Domiciliary and Hospital-based Stroke Rehabilitation Age and Ageing. 23: 241-245. PMID 8085511 DOI: 10.1093/Ageing/23.3.241 |
0.291 |
|
| 2006 |
Philips Z, Whynes DK, Avis M. Testing the construct validity of willingness to pay valuations using objective information about risk and health benefit. Health Economics. 15: 195-204. PMID 16229053 DOI: 10.1002/hec.1054 |
0.286 |
|
| 2017 |
Salamanca-Balen N, Seymour J, Caswell G, Whynes D, Tod A. The costs, resource use and cost-effectiveness of Clinical Nurse Specialist-led interventions for patients with palliative care needs: A systematic review of international evidence. Palliative Medicine. 269216317711570. PMID 28655289 DOI: 10.1177/0269216317711570 |
0.285 |
|
| 2004 |
Whynes DK. Cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial. Journal of Medical Screening. 11: 11-5. PMID 15006108 DOI: 10.1258/096914104772950691 |
0.283 |
|
| 2007 |
Woolley C, Philips Z, Whynes DK, Cotton SC, Gray NM, Sharp L, Little J, Waugh NR. United Kingdom cervical cancer screening and the costs of time and travel. International Journal of Technology Assessment in Health Care. 23: 232-9. PMID 17493309 DOI: 10.1017/S026646230707016X |
0.283 |
|
| 1997 |
Baines D, Brigham P, Phillips, Tolley K, Whynes D. GP fundholding and prescribing in UK general practice Public Health. 111: 321-325. DOI: 10.1038/Sj.Ph.1900377 |
0.278 |
|
| 1998 |
Newell M, Dabis F, Tolley K, Whynes D. Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. Aids. 12: 1571-1580. PMID 9764775 DOI: 10.1097/00002030-199813000-00003 |
0.273 |
|
| 2008 |
Whynes DK. Could CT screening for lung cancer ever be cost effective in the United Kingdom? Cost Effectiveness and Resource Allocation : C/E. 6: 5. PMID 18302756 DOI: 10.1186/1478-7547-6-5 |
0.272 |
|
| 2007 |
Whynes DK, Philips Z, Avis M. Why do women participate in the English cervical cancer screening programme? Journal of Health Economics. 26: 306-25. PMID 17010459 DOI: 10.1016/j.jhealeco.2006.08.007 |
0.271 |
|
| 2010 |
Sundaram RO, Schratt W, Hegarty J, Whynes D, Grevitt MP. A Cost-Utility Analysis of Lumbar Total Disc Replacement Compared with Circumferential Spinal Fusion The Spine Journal. 10. DOI: 10.1016/J.Spinee.2010.07.239 |
0.263 |
|
| 1996 |
Whynes D, Baines D. Predicting activity and workload in general practice from the demographic structure of the practice population. Journal of Health Services Research & Policy. 1: 128-134. PMID 10180858 DOI: 10.1177/135581969600100303 |
0.262 |
|
| 2009 |
Sach TH, Whynes DK. Men and women: beliefs about cancer and about screening. Bmc Public Health. 9: 431. PMID 19930703 DOI: 10.1186/1471-2458-9-431 |
0.262 |
|
| 2018 |
Sprigg N, Flaherty K, Appleton JP, Salman RA, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R, Czlonkowska A, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Krishnan K, ... ... Whynes D, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet (London, England). PMID 29778325 DOI: 10.1016/S0140-6736(18)31033-X |
0.261 |
|
| 2013 |
Sprigg N, Selby J, Fox L, Berge E, Whynes D, Bath PMW. Very low quality of life after acute stroke: Data from the efficacy of nitric oxide in stroke trial Stroke. 44: 3458-3462. PMID 24149005 DOI: 10.1161/Strokeaha.113.002201 |
0.26 |
|
| 2016 |
Sprigg N, Robson K, Bath P, Dineen R, Roberts I, Robinson T, Roffe C, Werring D, Al-Shahi Salman R, Pocock S, Duley L, England T, Whynes D, Ciccone A, Laska AC, et al. Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 27048694 DOI: 10.1177/1747493016641960 |
0.26 |
|
| 2000 |
Duggan A, Elliot C, Tolley K, Whynes D, Hawkey CJ, Logan RF. Randomised controlled trial of four dyspepsia management strategies in primary care with 12 months follow-up Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)83864-0 |
0.259 |
|
| 2003 |
Whynes DK, Frew E, Wolstenholme JL. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening. Journal of Health Economics. 22: 555-74. PMID 12842315 DOI: 10.1016/S0167-6296(03)00006-7 |
0.25 |
|
| 2015 |
Lim WS, Brittain C, Duley L, Edwards S, Gordon S, Montgomery A, Nguyen-Van-Tam J, Read R, Whitham D, Whynes D, Woodhead M, Wootton D. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. Health Technology Assessment (Winchester, England). 19: 1-78, vii-viii. PMID 25716702 DOI: 10.3310/Hta19160 |
0.248 |
|
| 2014 |
McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, Holemans JA, Ledson M, Screaton N, Rintoul RC, Hands CJ, Lifford K, Whynes D, Kerr KM, Page R, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prevention Research (Philadelphia, Pa.). 7: 362-71. PMID 24441672 DOI: 10.1158/1940-6207.CAPR-13-0206 |
0.245 |
|
| 2004 |
Whynes DK. Economics of cancer screening programs. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 61-9. PMID 19807336 DOI: 10.1586/14737167.4.1.61 |
0.245 |
|
| 1997 |
Pittman A, Bailey V, Whynes D, James V. Nottinghams pregnancy diary: A method of evaluating maternity care The British Journal of Midwifery. 5: 630-637. DOI: 10.12968/Bjom.1997.5.10.630 |
0.244 |
|
| 1998 |
Ennew C, Whynes D, Jolleys J, Robinson P. Entrepreneurship and Innovation Among GP Fundholders Public Money & Management. 18: 59-64. DOI: 10.1111/1467-9302.00105 |
0.236 |
|
| 2004 |
Renehan AG, O'Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. Bmj (Clinical Research Ed.). 328: 81. PMID 14715603 DOI: 10.1136/bmj.328.7431.81 |
0.226 |
|
| 2019 |
Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Ciccone A, Collins R, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Karlinski M, Krishnan K, Laska AC, ... ... Whynes D, et al. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. Health Technology Assessment (Winchester, England). 23: 1-48. PMID 31322116 DOI: 10.3310/Hta23350 |
0.224 |
|
| 2006 |
Bladin C, Chen C, Caso, Desfontaines P, Czlonkowska A, Gommans J, Lees K, Sandercock P, Baigent C, Wardlaw J, Dineen R, Navarro J, Phillips S, Wang Y, Wong L, ... ... Whynes D, et al. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122) Scopus. PMID 18706028 DOI: 10.1111/J.1747-4949.2006.00059.X |
0.223 |
|
| 2021 |
Field JK, Vulkan D, Davies MPA, Baldwin DR, Brain KE, Devaraj A, Eisen T, Gosney J, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, ... ... Whynes DK, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. The Lancet Regional Health. Europe. 10: 100179. PMID 34806061 DOI: 10.1016/j.lanepe.2021.100179 |
0.221 |
|
| 2016 |
Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, ... ... Whynes DK, et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technology Assessment (Winchester, England). 20: 1-146. PMID 27224642 DOI: 10.3310/hta20400 |
0.218 |
|
| 1989 |
Giggs J, Bean P, Whynes D, Wilkinson C. Class A drug users: prevalence and characteristics in greater Nottingham. Addiction. 84: 1473-1480. PMID 2611430 DOI: 10.1111/J.1360-0443.1989.Tb03929.X |
0.215 |
|
| 2004 |
Frew EJ, Wolstenholme JL, Whynes DK. Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats. Health Policy (Amsterdam, Netherlands). 68: 289-98. PMID 15113640 DOI: 10.1016/j.healthpol.2003.10.003 |
0.211 |
|
| 2003 |
Sach TH, Whynes DK. Measuring indirect costs: is there a problem? Applied Health Economics and Health Policy. 2: 135-9. PMID 14984278 |
0.204 |
|
| 1986 |
Wiseman M, Bean P, Ferris J, Whynes D, Klein R, O'Higgins M. Welfare@@@In Defense of Welfare@@@The Future of Welfare Journal of Policy Analysis and Management. 6: 123. DOI: 10.2307/3324094 |
0.204 |
|
| 2003 |
Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Education Research. 18: 318-28. PMID 12828233 |
0.202 |
|
| 2002 |
Philips Z, Gray N, Avis M, Whynes DK. Psychosocial and economic aspects of a trial of management of mild and borderline cervical abnormalities (TOMBOLA). European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society. 6: 23-9. PMID 12849606 |
0.2 |
|
| 2012 |
Field J, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Whynes D, Williamson P. Tuberculosis through the rose tinted spectacles of the EBUS endoscopist: be aware of the bias response Thorax. 67: 650-650. DOI: 10.1136/Thoraxjnl-2011-200822 |
0.183 |
|
| 2003 |
Frew EJ, Whynes DK, Wolstenholme JL. Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 23: 150-9. PMID 12693877 DOI: 10.1177/0272989X03251245 |
0.156 |
|
| 2007 |
Whynes DK, Sach TH. WTP and WTA: do people think differently? Social Science & Medicine (1982). 65: 946-57. PMID 17499410 DOI: 10.1016/j.socscimed.2007.04.014 |
0.151 |
|
| 2006 |
Yu CP, Whynes DK, Sach TH. Assessing progressivity of out-of-pocket payment: with illustration to Malaysia. The International Journal of Health Planning and Management. 21: 193-210. PMID 17044546 |
0.145 |
|
| 2002 |
Whynes DK, Baines DL. Primary care physicians' attitudes to health care reform in England. Health Policy (Amsterdam, Netherlands). 60: 111-32. PMID 11897372 |
0.145 |
|
| 2022 |
Morgan O, Elsayed M, Ramakrishnan Y, McGlashan J, Whynes D, McCahon R. Cost comparison study of reusable and disposable rhinolaryngoscopes in a large English teaching hospital. The Journal of Laryngology and Otology. 1-25. PMID 35000627 DOI: 10.1017/S0022215121004497 |
0.143 |
|
| 2006 |
Philips Z, Avis M, Whynes DK. Introducing HPV triage into the English cervical cancer screening program: consequences for participation. Women & Health. 43: 17-34. PMID 17000609 DOI: 10.1300/J013v43n02_02 |
0.142 |
|
| 2007 |
Sach TH, Smith RD, Whynes DK. A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow? Pharmacoeconomics. 25: 107-27. PMID 17249854 |
0.138 |
|
| 2009 |
Whynes DK. Responsiveness of the EQ-5D to HADS-identified anxiety and depression. Journal of Evaluation in Clinical Practice. 15: 820-5. PMID 19811595 DOI: 10.1111/j.1365-2753.2008.01102.x |
0.13 |
|
| 2002 |
Holroyd S, Bailey V, James V, Pitman A, Whynes DK. Professional attitudes to Changing Childbirth in Nottingham, UK. International Journal of Nursing Studies. 39: 177-86. PMID 11755448 |
0.129 |
|
| 2013 |
Whynes DK, Sharp L, Cotton SC, Cruickshank M, Gray NM, Little J, Waugh N. Impact of alternative management policies on health-related quality of life in women with low-grade abnormal cervical cytology referred for colposcopy. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 169: 88-92. PMID 23481576 DOI: 10.1016/j.ejogrb.2013.02.006 |
0.126 |
|
| 2004 |
Whynes DK, Wolstenholme JL, Frew E. Evidence of range bias in contingent valuation payment scales. Health Economics. 13: 183-90. PMID 14737755 DOI: 10.1002/hec.809 |
0.121 |
|
| 2012 |
Whynes DK, McCahon RA, Ravenscroft A, Hardman J. Cost effectiveness of epidural steroid injections to manage chronic lower back pain. Bmc Anesthesiology. 12: 26. PMID 23016755 DOI: 10.1186/1471-2253-12-26 |
0.115 |
|
| 2006 |
Barton GR, Avery AJ, Whynes DK. Accounting for the increase in NSAID expenditure: substitution or leakage? Cost Effectiveness and Resource Allocation : C/E. 4: 9. PMID 16737538 DOI: 10.1186/1478-7547-4-9 |
0.111 |
|
| 2008 |
Yu CP, Whynes DK, Sach TH. Equity in health care financing: The case of Malaysia. International Journal For Equity in Health. 7: 15. PMID 18541025 DOI: 10.1186/1475-9276-7-15 |
0.111 |
|
| 2013 |
Owens T, Evangelou N, Whynes DK. Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. 14: 315-21. PMID 22270579 DOI: 10.1007/s10198-012-0378-7 |
0.108 |
|
| 2002 |
Jenkins D, Philips Z, Grisaffiî K, Whynes DK. The boundaries of cellular pathology: how pathologists see their clinical role. The Journal of Pathology. 196: 356-63. PMID 11857501 DOI: 10.1002/path.1041 |
0.107 |
|
| 2021 |
Goyal A, Mann GB, Fallowfield L, Duley L, Reed M, Dodwell D, Coleman RE, Fakis A, Newcombe R, Jenkins V, Whitham D, Childs M, Whynes D, Keeley V, Ellis I, et al. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes. Bmj Open. 11: e054365. PMID 34857578 DOI: 10.1136/bmjopen-2021-054365 |
0.101 |
|
| 2013 |
Whynes DK, Sprigg N, Selby J, Berge E, Bath PM. Testing for differential item functioning within the EQ-5D Medical Decision Making. 33: 252-260. PMID 23184462 DOI: 10.1177/0272989X12465016 |
0.098 |
|
| 2011 |
Yu CP, Whynes DK, Sach TH. Reform towards National Health Insurance in Malaysia: the equity implications. Health Policy (Amsterdam, Netherlands). 100: 256-63. PMID 21129808 DOI: 10.1016/j.healthpol.2010.10.018 |
0.095 |
|
| 2005 |
Whynes DK, Frew EJ, Wolstenholme JL. Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats. International Journal of Health Care Finance and Economics. 5: 369-86. PMID 16378240 DOI: 10.1007/s10754-005-4014-2 |
0.09 |
|
| 2013 |
Whynes DK. Does the correspondence between EQ-5D health state description and VAS score vary by medical condition? Health and Quality of Life Outcomes. 11: 155. PMID 24034630 DOI: 10.1186/1477-7525-11-155 |
0.083 |
|
| 2008 |
Whynes DK. Correspondence between EQ-5D health state classifications and EQ VAS scores. Health and Quality of Life Outcomes. 6: 94. PMID 18992139 DOI: 10.1186/1477-7525-6-94 |
0.078 |
|
| 2009 |
Whynes DK. Deprivation and self-reported health: are there 'Scottish effects' in England and Wales? Journal of Public Health (Oxford, England). 31: 147-53. PMID 18946154 DOI: 10.1093/pubmed/fdn089 |
0.077 |
|
| 2005 |
Whynes DK, Philips Z, Frew E. Think of a number... any number? Health Economics. 14: 1191-5. PMID 15945042 DOI: 10.1002/hec.1001 |
0.065 |
|
| 2008 |
Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years. Health Economics. 17: 815-32. PMID 17893863 DOI: 10.1002/hec.1298 |
0.048 |
|
| 2011 |
Kumar VM, Whynes DK. Explaining variation in the uptake of HPV vaccination in England. Bmc Public Health. 11: 172. PMID 21426539 DOI: 10.1186/1471-2458-11-172 |
0.048 |
|
| 2013 |
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Whynes D, Williamson P. Authors' response. Thorax. 68: 105. PMID 23359880 DOI: 10.1136/thoraxjnl-2012-202442 |
0.039 |
|
| 2005 |
Sach TH, Whynes DK. Paediatric cochlear implantation: the views of parents. International Journal of Audiology. 44: 400-7. PMID 16136790 |
0.02 |
|
| Hide low-probability matches. |